Literature DB >> 19661438

Differential effects of pioglitazone on advanced atherosclerotic lesions.

Edward Thorp, Ira Tabas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19661438      PMCID： PMC2731152          DOI： 10.2353/ajpath.2009.090483

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  5 in total

Review 1.  Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-01       Impact factor: 8.311

2.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Authors:  John A Dormandy; Bernard Charbonnel; David J A Eckland; Erland Erdmann; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene; Meng H Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokán; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Skrha; Ulf Smith; Jan Taton
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

3.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.

Authors:  Edward Thorp; George Kuriakose; Yatrik M Shah; Frank J Gonzalez; Ira Tabas
Journal:  Circulation       Date:  2007-10-22       Impact factor: 29.690

5.  Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.

Authors:  Hideaki Nakaya; Barbara D Summers; Andrew C Nicholson; Antonio M Gotto; David P Hajjar; Jihong Han
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307
  5 in total
  2 in total

1.  Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.

Authors:  Kiyuk Chang; Sanjeev A Francis; Elena Aikawa; Jose-Luiz Figueiredo; Rainer H Kohler; Jason R McCarthy; Ralph Weissleder; Jorge Plutzky; Farouc A Jaffer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-05       Impact factor: 8.311

2.  The Role of Efferocytosis in Atherosclerosis.

Authors:  Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Circulation       Date:  2017-01-31       Impact factor: 29.690
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.